New Clinical Insights in Cognitive Health at Vitafoods Europe 2026
New Clinical Insights in Cognitive Health Clinical Evidence on RiboDIET ® and RiboMIX SC in Mild Cognitive Impairment Prosol will present new clinical data on RiboDIET ® and RiboMIX SC for the support of cognitive function in individuals with Mild Cognitive Impairment (MCI)—an early stage of cognitive decline where daily activities remain largely unaffected. These two yeast-derived nucleotide-based ingredients are designed to support cognitive performance and promote healthy aging. A randomized, controlled clinical study evaluated supplementation with: • RiboDIET ® (250 mg/day) • RiboMIX SC (350 mg/day) After 6 months, significant improvements in cognitive performance and mental well-being were observed. These findings highlight the potential of RiboDIET ® and RiboMIX SC as science-backed ingredients for next- generation cognitive health [...]




